Increased expression of TLR3 in lymph nodes during simian immunodeficiency virus infection: implications for inflammation and immunodeficiency.
As pattern recognition receptors, TLRs signal and induce expression of multiple host defense genes including proinflammatory cytokines and chemokines. To investigate the mechanisms of up-regulation of proinflammatory cytokines and chemokines during SIV infection in rhesus macaques, we measured the relative levels of expression of TLRs 1-10 in lymphoid tissues during different stages of SIV infection. By real-time RT-PCR, TLR3 was determined to be up-regulated in macaque lymph nodes (LN) throughout the course of infection, whereas TLR9 was down-regulated during early stages of infection. CXCL9/Mig, CXCL10/IP-10, IFN-gamma, and IFN-alpha mRNAs were also increased during acute SIV infection and AIDS. Treatment of macaque spleen and LN cells with TLR3 and TLR9 ligands led to the induction of these same genes. TLR3 stimulation had disparate effects on viral transcription and viral replication, because poly(I:C), a model TLR3 ligand, stimulated the viral promoter but potently inhibited SIV replication in primary cultures of macaque spleen and LN cells. These findings identify roles for TLR3 inflammation in lymphoid tissues and in the immunopathogenesis of HIV-1/SIV, and suggest that TLR3 ligands could potentially be used to flush out latently infected cells that persist during antiretroviral therapies.
Sanghavi
Sonali K
SK
Department of Infectious Diseases and Microbiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA 15261, USA.
Reinhart
Todd A
TA
D000818:Animals; D002460:Cell Line; D005786:Gene Expression Regulation / Q000276:immunology; D006801:Humans; D018836:Inflammation Mediators / Q000378:metabolism / Q000502:physiology*; D016898:Interferon-alpha / Q000502:physiology; D008024:Ligands; D008198:Lymph Nodes / Q000276:immunology / Q000378:metabolism*; D008253:Macaca mulatta; D011089:Polydeoxyribonucleotides / Q000378:metabolism; D012333:RNA, Messenger / Q000378:metabolism; D016097:Simian Acquired Immunodeficiency Syndrome / Q000276:immunology / Q000378:metabolism*; D015302:Simian Immunodeficiency Virus / Q000276:immunology* / Q000378:metabolism; D013154:Spleen / Q000166:cytology / Q000378:metabolism; D051196:Toll-Like Receptor 3 / Q000096:biosynthesis* / Q000235:genetics*; D051217:Toll-Like Receptor 9 / Q000378:metabolism; D014158:Transcription, Genetic / Q000502:physiology; D015854:Up-Regulation / Q000502:physiology; D014779:Virus Replication / Q000502:physiology
D018836:Inflammation Mediators; D016898:Interferon-alpha; D008024:Ligands; D011089:Polydeoxyribonucleotides; D012333:RNA, Messenger; D051196:Toll-Like Receptor 3; D051217:Toll-Like Receptor 9; C031156:poly d(I-C)